Aplastic anaemia: From genetic susceptibility to epigenetic dysregulation

Junchen Lai; Xinan Wang

doi:10.1002/ctd2.70145

Clinical and Translational Discovery ›› 2026, Vol. 6 ›› Issue (2) :e70145 DOI: 10.1002/ctd2.70145

INVITED LETTER

Aplastic anaemia: From genetic susceptibility to epigenetic dysregulation

Author information +

History +

PDF (602KB)

Cite this article

Download citation ▾

Junchen Lai, Xinan Wang. Aplastic anaemia: From genetic susceptibility to epigenetic dysregulation. Clinical and Translational Discovery, 2026, 6 (2) : e70145 DOI:10.1002/ctd2.70145

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Young NS. Aplastic anaemia. N Engl J Med. 2018;379(17):1643-1656.

[2]	Scheinberg P, Brummendorf THH, Peffault De Latour R, et al. Incidence, time to diagnosis, and therapeutic landscape of aplastic anaemia: results from a Large United States Claims Database. Blood. 2024;144(Supplement 1):2329.

[3]	Liu C, Shao Z. Aplastic anaemia in China. J Transl Int Med. 2018;6(3):134-137.

[4]	Yoshizato T, Dumitriu B, Hosokawa K, et al. Somatic mutations and clonal hematopoiesis in aplastic anaemia. N Engl J Med. 2015;373(1):35-47.

[5]	Wang P, Jiang W, Lai T, et al. Germline variants in acquired aplastic anaemia: current knowledge and future perspectives. Haematologica. 2024;109(9):2778-2789.

[6]	Giudice V, Selleri C. Aplastic anaemia: pathophysiology. Semin Hematol. 2022;59(1):13-20.

[7]	Ferreira LMR, Muller YD, Bluestone JA, et al. Next-generation regulatory T cell therapy. Nat Rev Drug Discov. 2019;18(10):749-769.

[8]	Lai J, Chen F, Miao Y, et al. DNA methylation variability in pediatric aplastic anaemia contributes to T-cell differentiation. Clin Transl Med. 2026;16(1):e70588.

[9]	Zhang J, Liu T, Duan Y, et al. Single-cell analysis highlights a population of Th17-polarized CD4(+) naïve T cells showing IL6/JAK3/STAT3 activation in pediatric severe aplastic anemia. J Autoimmun. 2023;136:103026.

[10]	Koga T, Hedrich CM, Mizui M, et al. CaMK4-dependent activation of AKT/mTOR and CREM-alpha underlies autoimmunity-associated Th17 imbalance. J Clin Invest. 2014;124(5):2234-2245.

RIGHTS & PERMISSIONS

2026 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.